← Back to Search

Postpartumcare.ca (Web-Enabled Intervention) for Postpartum Depression (SUPPORT Trial)

Phase 2

Waitlist Available

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the pass will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period

Awards & highlights

SUPPORT Trial Summary

This trial will test how well postpartumcare.ca works to help postpartum depression and anxiety in British Columbia.

Eligible Conditions

Postpartum Depression
Postpartum Anxiety
Perinatal Disorder

SUPPORT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the epds will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the epds will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period

This trial's timeline: 3 weeks for screening, Varies for treatment, and the epds will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline Postpartum Anxiety at 4 weeks and 6 weeks, evaluated using the Perinatal Anxiety Screening Scale (PASS).

Change from Baseline Postpartum Depression at 4 weeks and 6 weeks, evaluated using the Edinburgh Postnatal Depression Scale (EPDS).

Website metrics including average time on page, average session duration, returning visitors, and number of pages visited per session.

+4 more

SUPPORT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Fifty participants will be randomized to the intervention group, receiving immediate access to postpartumcare.ca for a period of 4 weeks. Intervention group participants may use postpartumcare.ca as often as desired for the duration of the 4-week intervention period. Following the 4-week intervention period and a 2-week follow-up period, intervention group participants will retain access to postpartumcare.ca.

Group II: Waitlist ControlActive Control1 Intervention

Fifty participants will be randomized to a waitlist control group, receiving treatment as usual (TAU) for a period of 4 weeks. Following the 4-week intervention period and a 2-week follow-up period, waitlist control participants will receive access to postpartumcare.ca.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor

1,415 Previous Clinical Trials

2,466,913 Total Patients Enrolled

1 Trials studying Postpartum Depression

550 Patients Enrolled for Postpartum Depression

Women's Health Research Institute of British ColumbiaOTHER

5 Previous Clinical Trials

16,216 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,344 Previous Clinical Trials

26,453,314 Total Patients Enrolled

4 Trials studying Postpartum Depression

1,085 Patients Enrolled for Postpartum Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many research subjects are currently enrolled in this trial?

"The latest information from clinicaltrials.gov suggests that this research is still looking for volunteers. This trial was initially announced on April 20th, 2022 and has been updated as recently as May 16th, 2022. So far, only 1 medical facility is participating but they are hoping to enroll 100 patients in total."

Answered by AI

Are there any seats left in this research project?

"That is correct, the listings on clinicaltrials.gov currently show that this study is open for enrollment. This trial was originally posted on April 20th, 2022 and edited more recently on May 16th, 2022. They are looking for 100 patients from 1 location to participate."

Answered by AI